Ford recalls 242,669 US vehicles, NHTSA says-March 2024-www.financetom.com

Ford recalls 242,669 US vehicles, NHTSA says

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Ford recalls 242,669 US vehicles, NHTSA says

May 1, 2024 3:27 AM

May 1 (Reuters) - Ford is recalling 242,669 units

of its 2022-2024 Maverick vehicles over the failure of rear tail

lights to illuminate, causing it to reduce the vehicle's

visibility, the National Highway Traffic Safety Administration

(NHTSA) said on Wednesday.

Previous page： US court blocks Kroger's $25 billion acquisition of grocery rival Albertsons Next page： Siga's mpox drug did not improve lesion resolution or pain, NIH study finds

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

US court blocks Kroger's $25 billion acquisition of grocery rival Albertsons

Dec 10, 2024

Dec 10 (Reuters) - A U.S. judge blocked the pending $25 billion merger of U.S. grocery chains Kroger ( KR ) and Albertsons ( ACI ) on Tuesday, siding with the U.S. Federal Trade Commission in a win for the Biden administration. The FTC argued at a three-week trial in Portland, Oregon, that the merger would eliminate head-to-head competition between...

Siga's mpox drug did not improve lesion resolution or pain, NIH study finds

Dec 10, 2024

Dec 10 (Reuters) - Siga Technologies' ( SIGA ) antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults affected by the clade II strain of mpox, according to a National Institutes of Health study published on Tuesday. ...

Avast antivirus owner Gen Digital acquires MoneyLion in $1 billion deal

Dec 10, 2024

(Reuters) - Norton and Avast owner Gen Digital ( GEN ) has agreed to buy fintech firm MoneyLion ( ML ) in an all-cash deal valued at about $1 billion to beef up its consumer finance offerings, the companies said on Tuesday. Gen Digital ( GEN ) will pay $82 for each MoneyLion ( ML ) share, a 6.5% premium...

Jazz Pharmaceuticals Likely to Launch FDA-Approved Biliary Tract Cancer Treatment in 2025, RBC Says

Dec 10, 2024

03:32 PM EST, 12/10/2024 (MT Newswires) -- Jazz Pharmaceuticals' ( JAZZ ) investor event on Wednesday is expected to set the stage for commercial launch possibly next year of its biliary tract cancer treatment Ziihera, RBC Capital Markets said in a note. The US Food and Drug Administration's accelerated approval of Ziihera brings Jazz a step closer towards new revenue...